Skip to main content
. 2021 Feb 4;11:3092. doi: 10.1038/s41598-021-82747-7

Figure 2.

Figure 2

Target concentration dependent effects of BT200 on von Willebrand factor (VWF) activity (A) and VWF ristocetin cofactor activity (B) in patients with large artery atherosclerosis stroke or transient ischemic attacks when stratified into groups with normal (< 180%) or elevated (> 180%) VWF activity. Data are presented as median values and interquartile ranges and baseline is presented as 0.01 for better visualization on the log scale.